CUSIP 29337E102COMELVNQ4 2025
41 filings · latest Feb 17, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Orbimed Advisors LLC | 7.96M | $122.58M |
| 2 | Fmr LLC | 7.11M | $109.46M |
| 3 | Commodore Capital LP | 4.69M | $72.27M |
| 4 | Vestal Point Capital, LP | 3.83M | $58.98M |
| 5 | Fairmount Funds Management LLC | 3.71M | $57.16M |
| 6 | Blackrock, Inc. | 3.61M | $55.65M |
| 7 | Polar Capital Holdings PLC | 3.51M | $54.11M |
| 8 | Vr Adviser, LLC | 3.23M | $49.69M |
| 9 |
| 4 | Aug 14, 2025 | Commodore Capital LP | 13G/A | 11.0% | 6.02M | SEC |
| 5 | Aug 14, 2025 | Polar Capital Holdings PLC | 13G | 5.2% | 2.54M | SEC |
| 6 | Aug 14, 2025 | Fairmount Funds Management LLC | 13G/A | 11.0% | 3.71M | SEC |
| 7 | Jul 17, 2025 | Blackrock, Inc. | 13G/A | 5.1% | 2.94M | SEC |
| 8 | Jun 17, 2025 | Orbimed Advisors LLC | 13D/A | 13.4% | — | SEC |
| 9 | Feb 14, 2025 | Polar Capital Holdings PLC | 13G/A | 4.9% | 2.39M | SEC |
| 10 | Feb 14, 2025 | Fairmount Funds Management LLC | 13G/A | 11.0% | 3.20M | SEC |
See the full Schedule 13D/13G history for Enliven Therapeutics Inc.
Unlock full history| 2.80M |
| $43.15M |
| 10 | Janus Henderson Group PLC | 1.67M | $25.74M |